Literature DB >> 26139657

Methotrexate for maintenance of remission in IgG4-related disease.

Emanuel Della-Torre1, Corrado Campochiaro2, Enrica Paola Bozzolo3, Lorenzo Dagna2, Raffaella Scotti3, Roberto Nicoletti4, John H Stone5, Maria Grazia Sabbadini2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26139657     DOI： 10.1093/rheumatology/kev244

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  12 in total

Review 1.  Immunology of IgG4-related disease.

Authors:  E Della-Torre; M Lanzillotta; C Doglioni
Journal:  Clin Exp Immunol       Date:  2015-06-08       Impact factor: 4.330

2.  "How I manage" IgG4-Related Disease.

Authors:  Emanuel Della-Torre; John H Stone
Journal:  J Clin Immunol       Date:  2016-09-26       Impact factor: 8.317

Review 3.  IgG4-Related Disease: Beyond Glucocorticoids.

Authors:  Mitsuhiro Akiyama; Tsutomu Takeuchi
Journal:  Drugs Aging       Date:  2018-04       Impact factor: 3.923

4.  European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations.

Authors:  J-Matthias Löhr; Ulrich Beuers; Miroslav Vujasinovic; Domenico Alvaro; Jens Brøndum Frøkjær; Frank Buttgereit; Gabriele Capurso; Emma L Culver; Enrique de-Madaria; Emanuel Della-Torre; Sönke Detlefsen; Enrique Dominguez-Muñoz; Piotr Czubkowski; Nils Ewald; Luca Frulloni; Natalya Gubergrits; Deniz Guney Duman; Thilo Hackert; Julio Iglesias-Garcia; Nikolaos Kartalis; Andrea Laghi; Frank Lammert; Fredrik Lindgren; Alexey Okhlobystin; Grzegorz Oracz; Andrea Parniczky; Raffaella Maria Pozzi Mucelli; Vinciane Rebours; Jonas Rosendahl; Nicolas Schleinitz; Alexander Schneider; Eric Fh van Bommel; Caroline Sophie Verbeke; Marie Pierre Vullierme; Heiko Witt
Journal:  United European Gastroenterol J       Date:  2020-06-18       Impact factor: 4.623

5.  Immunoglobulin G4-related pleuritis - A case report.

Authors:  Marta E Gajewska; Beata A Rychwicka-Kielek; Kathina Sørensen; Magdalena Kubik; Ole Hilberg; Elisabeth Bendstrup
Journal:  Respir Med Case Rep       Date:  2016-05-24

Review 6.  Neurological Manifestations of IgG4-Related Disease.

Authors:  Bernardo Baptista; Alina Casian; Harsha Gunawardena; David D'Cruz; Claire M Rice
Journal:  Curr Treat Options Neurol       Date:  2017-04       Impact factor: 3.598

7.  Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients.

Authors:  Mikael Ebbo; Aurélie Grados; Maxime Samson; Matthieu Groh; Anderson Loundou; Aude Rigolet; Benjamin Terrier; Constance Guillaud; Clarisse Carra-Dallière; Frédéric Renou; Agnieszka Pozdzik; Pierre Labauge; Sylvain Palat; Jean-Marie Berthelot; Jean-Loup Pennaforte; Alain Wynckel; Céline Lebas; Noémie Le Gouellec; Thomas Quémeneur; Karine Dahan; Franck Carbonnel; Gaëlle Leroux; Antoinette Perlat; Alexis Mathian; Patrice Cacoub; Eric Hachulla; Nathalie Costedoat-Chalumeau; Jean-Robert Harlé; Nicolas Schleinitz
Journal:  PLoS One       Date:  2017-09-15       Impact factor: 3.240

8.  Identifying clinical subgroups in IgG4-related disease patients using cluster analysis and IgG4-RD composite score.

Authors:  Jieqiong Li; Yu Peng; Yuelun Zhang; Panpan Zhang; Zheng Liu; Hui Lu; Linyi Peng; Liang Zhu; Huadan Xue; Yan Zhao; Xiaofeng Zeng; Yunyun Fei; Wen Zhang
Journal:  Arthritis Res Ther       Date:  2020-01-10       Impact factor: 5.156

9.  Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients.

Authors:  Liwen Wang; Panpan Zhang; Mu Wang; Ruie Feng; Yamin Lai; Linyi Peng; Yunyun Fei; Xuan Zhang; Yan Zhao; Xiaofeng Zeng; Fengchun Zhang; Wen Zhang
Journal:  Arthritis Res Ther       Date:  2018-04-10       Impact factor: 5.156

Review 10.  Renal Involvement in Retroperitoneal Fibrosis: Prevalence, Impact and Management Challenges.

Authors:  Ichiro Mizushima; Mitsuhiro Kawano
Journal:  Int J Nephrol Renovasc Dis       Date:  2021-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.